Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

MLA

Owaki, Takayuki, et al. “Synthetic Retinoid-Mediated Preconditioning of Cancer-Associated Fibroblasts and Macrophages Improves Cancer Response to Immune Checkpoint Blockade.” British Journal of Cancer, vol. 131, no. 2, July 2024, pp. 372–86. EBSCOhost, https://doi.org/10.1038/s41416-024-02734-3.

APA

Owaki, T., Iida, T., Miyai, Y., Kato, K., Hase, T., Ishii, M., Ando, R., Hinohara, K., Akashi, T., Mizutani, Y., Ishikawa, T., Mii, S., Shiraki, Y., Esaki, N., Yamamoto, M., Tsukamoto, T., Nomura, S., Murakami, T., Takahashi, M., … Enomoto, A. (2024). Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade. British Journal of Cancer, 131(2), 372–386. https://doi.org/10.1038/s41416-024-02734-3

Chicago

Owaki, Takayuki, Tadashi Iida, Yuki Miyai, Katsuhiro Kato, Tetsunari Hase, Makoto Ishii, Ryota Ando, et al. 2024. “Synthetic Retinoid-Mediated Preconditioning of Cancer-Associated Fibroblasts and Macrophages Improves Cancer Response to Immune Checkpoint Blockade.” British Journal of Cancer 131 (2): 372–86. doi:10.1038/s41416-024-02734-3.